TY  - JOUR
AU  - Bayoumi, Ali
AU  - Elsayed, Asmaa
AU  - Han, Shuanglin
AU  - Petta, Salvatore
AU  - Adams, Leon A
AU  - Aller, Rocio
AU  - Khan, Anis
AU  - García-Monzón, Carmelo
AU  - Arias-Loste, María Teresa
AU  - Miele, Luca
AU  - Latchoumanin, Olivier
AU  - Alenizi, Shafi
AU  - Gallego-Durán, Rocio
AU  - Fischer, Janett
AU  - Berg, Thomas
AU  - Craxì, Antonio
AU  - Metwally, Mayada
AU  - Qiao, Liang
AU  - Liddle, Christopher
AU  - Yki-Järvinen, Hannele
AU  - Bugianesi, Elisabetta
AU  - Romero-Gomez, Manuel
AU  - George, Jacob
AU  - Eslam, Mohammed
PY  - 2021
DO  - 10.1002/advs.202004168
UR  - http://hdl.handle.net/10668/18013
T2  - Advanced science (Weinheim, Baden-Wurttemberg, Germany)
AB  - Fibroblast growth factor 21 (FGF21) is a liver-derived hormone with pleiotropic beneficial effects on metabolism. Paradoxically, FGF21 levels are elevated in metabolic diseases. Interventions that restore metabolic homeostasis reduce FGF21. Whether...
LA  - en
KW  - fibroblast growth factor 21
KW  - genetics
KW  - metabolic
KW  - metabolic associated fatty liver disease
KW  - Cells, Cultured
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Fatty Liver
KW  - Fibroblast Growth Factors
KW  - Humans
KW  - Inflammation
KW  - Liver
TI  - Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus.
TY  - research article
VL  - 8
ER  -